Tango Therapeutics TNGX Cash Paid For Leases
Cash Paid For Leases at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept tngx:CashPaidForLeases.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's cash paid for leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's cash paid for leases?
- Tango Therapeutics (TNGX) reported cash paid for leases of $1.45M in Q1 2026.
- How has Tango Therapeutics's cash paid for leases changed year-over-year?
- Tango Therapeutics's cash paid for leases decreased by 25.2% year-over-year, from $1.94M to $1.45M.
- What is the long-term trend for Tango Therapeutics's cash paid for leases?
- Over 4 years (2021 to 2025), Tango Therapeutics's cash paid for leases has grown at a 33.7% compound annual growth rate (CAGR), from -$1.84M to $5.86M.
- What does cash paid for leases mean?
- Represents the total cash outflows specifically allocated to lease payments for operating assets. This supplemental disclosure provides transparency into the cash impact of lease obligations that are otherwise embedded in operating activities. It is essential for evaluating the company's fixed cash commitments and overall liquidity position.